This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Laboratory Corporation Of America Holdings (LH): Today's Featured Health Services Loser

Laboratory Corporation of America Holdings (LH) pushed the Health Services industry lower today making it today's featured Health Services loser. The industry as a whole was unchanged today. By the end of trading, Laboratory Corporation of America Holdings fell $2.07 (-2.2%) to $92.55 on heavy volume. Throughout the day, 1.6 million shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 791,800 shares. The stock ranged in price between $92.23-$93.66 after having opened the day at $93.31 as compared to the previous trading day's close of $94.62. Other company's within the Health Services industry that declined today were: CombiMatrix Corporation (CBMX), down 14.9%, Sunshine Heart (SSH), down 14.8%, IsoRay (ISR), down 14.6%, and Stereotaxis (STXS), down 13.3%.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company in the United States. The company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of diseases. Laboratory Corporation of America Holdings has a market cap of $9.22 billion and is part of the health care sector. The company has a P/E ratio of 17.3, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 10.8% year to date as of the close of trading on Monday. Currently there are seven analysts that rate Laboratory Corporation of America Holdings a buy, two analysts rate it a sell, and eight rate it a hold.

TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Urologix (ULGX), up 11.3%, ZELTIQ Aesthetics (ZLTQ), up 7.1%, Misonix (MSON), up 6.6%, and Trius Therapeutics (TSRX), up 6.4%, were all gainers within the health services industry with UnitedHealth Group (UNH) being today's featured health services industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR (XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care (RXD).

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Submit an article to us!
DOW 17,018.88 -20.61 -0.12%
S&P 500 1,989.44 -2.93 -0.15%
NASDAQ 4,540.0160 +7.9120 0.17%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs